自Henle等(1976)首先报道检测血清EB病毒VCA-IgA抗体,用于诊断鼻咽癌以来,EB病毒感染与鼻咽癌的关系已受到普遍重视。为了了解EB病毒感染与肺癌有无关系,测定肺癌病人血清EB病毒VCA-IgA抗体对肺癌诊断有无帮助,作者检测了17例肺癌,32例非癌胸疾病人血清EB病毒VCA-IgA抗体,并以27例正常人作对照。现将结果报告如下。实验用EB病毒壳抗原的类淋巴细胞株做抗原靶细 Since Henle et al. (1976) first reported the detection of serum Epstein-Barr virus VCA-IgA antibodies for the diagnosis of nasopharyngeal carcinoma, the relationship between EBV infection and nasopharyngeal carcinoma has received widespread attention. In order to understand whether EB virus infection has relationship with lung cancer, serum EB virus VCA-IgA antibody in lung cancer patients has no help in the diagnosis of lung cancer. The authors tested 17 patients with lung cancer and 32 patients with non-cancer pleural disease serum Epstein-Barr virus VCA-IgA antibody. And 27 cases of normal controls. The results reported below. Experimental use of Epstein-Barr virus antigen-like lymphocyte strains as antigen targets